Business
Medicenna to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Medicenna to Present at the 19th Annual Rodman & Renshaw Global Investment Conference ...
About this update from Medicenna Therapeutics Corp.
[{"type":"text","content":"\n\n\n\nMedicenna to Present at the 19th Annual Rodman & Renshaw Global Investment Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-BOTTOM:1pt; BORDER-LEFT:1pt; PADDING-LEFT:0.50em; PADDING-RIGHT:0.50em; VERTICAL-ALIGN: BOTTOM; BORDER-TOP:1pt; BORDER-RIGHT:1pt\n}\n.prnsbt1{\nBORDER-TOP:1pt\n}\n.prnsbl1{\nBORDER-LEFT:1pt\n}\n.prnsbr1{\nBORDER-RIGHT:1pt\n}\n.prnsbb1{\nBORDER-BOTTOM:1pt\n}\n\n\n\n\n\n\nMedicenna to Present at the 19th Annual Rodman & Renshaw Global Investment Conference\nCanada NewsWire\nTORONTO and HOUSTON, TX, Sept. 6, 2017\n\n\n\nTORONTO and HOUSTON, TX, Sept. 6, 2017 /CNW/ - Medicenna Therapeutics Corp. (\"Medicenna\" or the \"Company\") (TSX: MDNA), a clinical stage immuno-oncology company, today announced that Dr. Fahar Merchant, Chairman, President and Chief Executive Officer will be presenting at the Rodman & Renshaw 19th Annual Global Investment Conference sponsored by H.C. Wainwright & Co., LLC.  in New York City on Tuesday, September 12th, at 4:15 PM Eastern Standard Time at the Lotte New York Palace Hotel. Medicenna is currently enrolling patients in a Phase 2b trial of MDNA55 for recurrent glioblastoma (rGB), the most common and uniformly fatal form of brain cancer.\n\nDr. Merchant will provide a corporate overview of the Company's recent activities and strategic direction and will be available along with Elizabeth Williams, Medicenna's Chief Financial Officer, for one-on-one meetings from September 10 – 12, 2017. \n\nPresentation details:\n\n\n\n\nTime:\n\n\n\n\n\n\n4:15 p.m. ET\n\n\n\nDate:\n\n\n\n\n\n\nTuesday, September 12, 2017\n\n\n\nLocation:\n\n\n\n\n\n\nLotte New York Palace Hotel, New York, NY\n\n\nA live webcast of the Medicenna presentation will be accessible by visiting:\n\nhttp://wsw.com/webcast/rrshq27/mdna/\n\nThe webcast will be archived shortly after the live event and will be available for 90 days through the Medicenna website at www.medicenna.com\n\nAbout Medicenna Therapeutics Corp. \n\nMedicenna is a clinical stage immuno-oncology company developing novel highly selecti...